These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
279 related articles for article (PubMed ID: 31904145)
1. Interference with SMO increases chemotherapy drug sensitivity of A2780/DDP cells by inhibiting the Hh/Gli signaling pathway. Ma S; Liu D; Tan W; Du B; Liu W; Li W; Jiao Y J Cell Biochem; 2020 Jun; 121(5-6):3256-3265. PubMed ID: 31904145 [TBL] [Abstract][Full Text] [Related]
2. DYRK1B as therapeutic target in Hedgehog/GLI-dependent cancer cells with Smoothened inhibitor resistance. Gruber W; Hutzinger M; Elmer DP; Parigger T; Sternberg C; Cegielkowski L; Zaja M; Leban J; Michel S; Hamm S; Vitt D; Aberger F Oncotarget; 2016 Feb; 7(6):7134-48. PubMed ID: 26784250 [TBL] [Abstract][Full Text] [Related]
3. Targeting of the Hedgehog signal transduction pathway suppresses survival of malignant pleural mesothelioma cells in vitro. You M; Varona-Santos J; Singh S; Robbins DJ; Savaraj N; Nguyen DM J Thorac Cardiovasc Surg; 2014 Jan; 147(1):508-16. PubMed ID: 24094913 [TBL] [Abstract][Full Text] [Related]
4. The Hedgehog signaling pathway promotes chemotherapy resistance via multidrug resistance protein 1 in ovarian cancer. Zhang H; Hu L; Cheng M; Wang Q; Hu X; Chen Q Oncol Rep; 2020 Dec; 44(6):2610-2620. PubMed ID: 33125122 [TBL] [Abstract][Full Text] [Related]
5. Targeting class I histone deacetylases by the novel small molecule inhibitor 4SC-202 blocks oncogenic hedgehog-GLI signaling and overcomes smoothened inhibitor resistance. Gruber W; Peer E; Elmer DP; Sternberg C; Tesanovic S; Del Burgo P; Coni S; Canettieri G; Neureiter D; Bartz R; Kohlhof H; Vitt D; Aberger F Int J Cancer; 2018 Mar; 142(5):968-975. PubMed ID: 29055107 [TBL] [Abstract][Full Text] [Related]
6. Interference with the expression of β-catenin reverses cisplatin resistance in A2780/DDP cells and inhibits the progression of ovarian cancer in mouse model. Zhao H; Wei W; Sun Y; Gao J; Wang Q; Zheng J DNA Cell Biol; 2015 Jan; 34(1):55-62. PubMed ID: 25211326 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of Gli leads to antitumor growth and enhancement of cisplatin-induced cytotoxicity in large cell neuroendocrine carcinoma of the lung. Ishiwata T; Iwasawa S; Ebata T; Fan M; Tada Y; Tatsumi K; Takiguchi Y Oncol Rep; 2018 Mar; 39(3):1148-1154. PubMed ID: 29328464 [TBL] [Abstract][Full Text] [Related]
8. Naringenin attenuates cell viability and migration of C6 glioblastoma cell line: a possible role of hedgehog signaling pathway. Sargazi ML; Juybari KB; Tarzi ME; Amirkhosravi A; Nematollahi MH; Mirzamohammdi S; Mehrbani M; Mehrabani M; Mehrabani M Mol Biol Rep; 2021 Sep; 48(9):6413-6421. PubMed ID: 34427888 [TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo inhibition of breast cancer cell growth by targeting the Hedgehog/GLI pathway with SMO (GDC-0449) or GLI (GANT-61) inhibitors. Benvenuto M; Masuelli L; De Smaele E; Fantini M; Mattera R; Cucchi D; Bonanno E; Di Stefano E; Frajese GV; Orlandi A; Screpanti I; Gulino A; Modesti A; Bei R Oncotarget; 2016 Feb; 7(8):9250-70. PubMed ID: 26843616 [TBL] [Abstract][Full Text] [Related]
10. Hedgehog-signaling is upregulated in non-producing human adrenal adenomas and antagonism of hedgehog-signaling inhibits proliferation of NCI-H295R cells and an immortalized primary human adrenal cell line. Werminghaus P; Haase M; Hornsby PJ; Schinner S; Schott M; Malendowicz LK; Lammers BJ; Goretzki PE; Müller-Mattheis V; Markus Giessing ; Willenberg HS J Steroid Biochem Mol Biol; 2014 Jan; 139():7-15. PubMed ID: 24063979 [TBL] [Abstract][Full Text] [Related]
11. Oridonin effectively reverses cisplatin drug resistance in human ovarian cancer cells via induction of cell apoptosis and inhibition of matrix metalloproteinase expression. Ma S; Tan W; Du B; Liu W; Li W; Che D; Zhang G Mol Med Rep; 2016 Apr; 13(4):3342-8. PubMed ID: 26935490 [TBL] [Abstract][Full Text] [Related]
12. Targeted inhibition of Hedgehog-GLI signaling by novel acylguanidine derivatives inhibits melanoma cell growth by inducing replication stress and mitotic catastrophe. Pietrobono S; Santini R; Gagliardi S; Dapporto F; Colecchia D; Chiariello M; Leone C; Valoti M; Manetti F; Petricci E; Taddei M; Stecca B Cell Death Dis; 2018 Feb; 9(2):142. PubMed ID: 29396391 [TBL] [Abstract][Full Text] [Related]
13. RETRACTED: CD44 expression denotes a subpopulation of gastric cancer cells in which Hedgehog signaling promotes chemotherapy resistance. Yoon C; Park DJ; Schmidt B; Thomas NJ; Lee HJ; Kim TS; Janjigian YY; Cohen DJ; Yoon SS Clin Cancer Res; 2014 Aug; 20(15):3974-88. PubMed ID: 24947926 [TBL] [Abstract][Full Text] [Related]
14. Gli affects the stemness and prognosis of epithelial ovarian cancer via homeobox protein NANOG. Zhao H; Li N; Pang Y; Zhao J; Wu X Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33313950 [TBL] [Abstract][Full Text] [Related]
15. Hedgehog signaling pathway affects the sensitivity of hepatoma cells to drug therapy through the ABCC1 transporter. Ding J; Zhou XT; Zou HY; Wu J Lab Invest; 2017 Jul; 97(7):819-832. PubMed ID: 28414325 [TBL] [Abstract][Full Text] [Related]
16. The intrahepatic signalling niche of hedgehog is defined by primary cilia positive cells during chronic liver injury. Grzelak CA; Martelotto LG; Sigglekow ND; Patkunanathan B; Ajami K; Calabro SR; Dwyer BJ; Tirnitz-Parker JE; Watkins DN; Warner FJ; Shackel NA; McCaughan GW J Hepatol; 2014 Jan; 60(1):143-51. PubMed ID: 23978713 [TBL] [Abstract][Full Text] [Related]
17. Targeting GLI factors to inhibit the Hedgehog pathway. Infante P; Alfonsi R; Botta B; Mori M; Di Marcotullio L Trends Pharmacol Sci; 2015 Aug; 36(8):547-58. PubMed ID: 26072120 [TBL] [Abstract][Full Text] [Related]
18. Hedgehog Signaling and Truncated GLI1 in Cancer. Doheny D; Manore SG; Wong GL; Lo HW Cells; 2020 Sep; 9(9):. PubMed ID: 32957513 [TBL] [Abstract][Full Text] [Related]
19. Targeting the hedgehog signal transduction pathway at the level of GLI inhibits neuroblastoma cell growth in vitro and in vivo. Wickström M; Dyberg C; Shimokawa T; Milosevic J; Baryawno N; Fuskevåg OM; Larsson R; Kogner P; Zaphiropoulos PG; Johnsen JI Int J Cancer; 2013 Apr; 132(7):1516-24. PubMed ID: 22949014 [TBL] [Abstract][Full Text] [Related]
20. Knockdown of MACC1 expression increases cisplatin sensitivity in cisplatin-resistant epithelial ovarian cancer cells. Zhang R; Shi H; Ren F; Li X; Zhang M; Feng W; Jia Y Oncol Rep; 2016 Apr; 35(4):2466-72. PubMed ID: 26794135 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]